Literature DB >> 17081079

Kidney disease and cardiovascular risk.

Marcello Tonelli1, Marc A Pfeffer.   

Abstract

Kidney failure and chronic kidney disease (CKD) are associated with accelerated cardiovascular disease, apparently because of a high burden of traditional vascular risk factors and possibly nontraditional risk factors such as inflammation, chronic volume overload, and abnormal calcium-phosphate metabolism. Although the burden of cardiovascular disease in CKD patients is well documented, potentially beneficial therapies appear to be underused in mild to moderate CKD and are relatively understudied in those with kidney failure. This review describes the epidemiology and pathophysiology of cardiovascular disease in CKD. We also discuss the clinical and public health implications of current knowledge and outline opportunities for further research.

Entities:  

Mesh:

Year:  2007        PMID: 17081079     DOI: 10.1146/annurev.med.58.071105.111123

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  19 in total

1.  Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling.

Authors:  Monica A Fisher; George W Taylor; Brady T West; Ellen T McCarthy
Journal:  Kidney Int       Date:  2010-10-06       Impact factor: 10.612

2.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 3.  Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology.

Authors:  Karim Abdur Rehman; Jorge Betancor; Bo Xu; Arnav Kumar; Carlos Godoy Rivas; Kimi Sato; Leslie P Wong; Craig R Asher; Allan L Klein
Journal:  Clin Cardiol       Date:  2017-09-05       Impact factor: 2.882

Review 4.  Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease.

Authors:  Monica A Fisher; Wenche S Borgnakke; George W Taylor
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-11       Impact factor: 2.894

5.  Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.

Authors:  Mahmut Ilker Yilmaz; Juan Jesús Carrero; Alberto Ortiz; Jose Luis Martín-Ventura; Alper Sonmez; Mutlu Saglam; Halil Yaman; Mujdat Yenicesu; Jesús Egido; Luis Miguel Blanco-Colio
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

6.  Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.

Authors:  Juan J Carrero; Alberto Ortiz; Abdul R Qureshi; Jose L Martín-Ventura; Peter Bárány; Olof Heimbürger; Belén Marrón; George Metry; Sunna Snaedal; Bengt Lindholm; Jesús Egido; Peter Stenvinkel; Luis M Blanco-Colio
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 8.237

7.  Identification, expression and tissue distribution of a renalase homologue from mouse.

Authors:  Jian Wang; Shaoling Qi; Wei Cheng; Li Li; Fu Wang; Ying-Zi Li; Shu-Ping Zhang
Journal:  Mol Biol Rep       Date:  2007-09-07       Impact factor: 2.316

8.  The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography.

Authors:  Ki Young Na; Chi Weon Kim; Young Rim Song; Ho Joon Chin; Dong-Wan Chae
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

9.  Periodontal disease: a covert source of inflammation in chronic kidney disease patients.

Authors:  Gener Ismail; Horia Traian Dumitriu; Anca Silvia Dumitriu; Fidan Bahtiar Ismail
Journal:  Int J Nephrol       Date:  2013-06-06

10.  The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.

Authors:  Stephanie Stringer; Praveen Sharma; Mary Dutton; Mark Jesky; Khai Ng; Okdeep Kaur; Iain Chapple; Thomas Dietrich; Charles Ferro; Paul Cockwell
Journal:  BMC Nephrol       Date:  2013-04-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.